This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Virginia Commonwealth University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Connor O'Hara
Introduction
Connor O'Hara is an accomplished inventor based in Richmond, VA. He has made significant strides in the field of anti-cancer research. His work focuses on developing novel compounds that target cancer stem cells, showcasing his commitment to advancing medical science.
Latest Patents
O'Hara holds a patent for "Lipidic analogs of anti-cancer stem cell agent." This patent describes a group of specific sulfated flavonoid agents that carry cholesterol modifications. These compounds exhibit promising in vivo anti-cancer activity through selective inhibition of cancer stem cells, while sparing adult or hematopoietic stem cells. The agents demonstrate high potency, excellent oral bioavailability, and a physiologically relevant therapeutic window. He has 1 patent to his name.
Career Highlights
Connor O'Hara is affiliated with Virginia Commonwealth University, where he contributes to groundbreaking research in cancer treatment. His work is pivotal in exploring new therapeutic avenues that could lead to more effective cancer therapies.
Collaborations
O'Hara collaborates with esteemed colleagues such as Umesh R Desai and Balaji Nagarajan. Their combined expertise enhances the research efforts at Virginia Commonwealth University.
Conclusion
Connor O'Hara's innovative work in developing anti-cancer agents highlights his dedication to improving cancer treatment. His contributions are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile